Day: November 15, 2021

DEER PARK, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the third quarter ended September 30, 2021. “Over the last month we have made tremendous advancements to our commercial portfolio. We gained two more FDA-approved products, EPRONTIA and carglumic acid, both of which should launch in the fourth quarter, and we are increasing ALKINDI SPRINKLE’s commercial footprint more than ten-fold through an attractive co-promotion arrangement with Tolmar Pharmaceuticals. These events put us in an even stronger position to deliver significant revenue and reach sustained profitability in 2022,” said Sean Brynjelsen, CEO of Eton Pharmaceuticals. Major Business UpdatesAcquired...

Company Continues Focus on Controlling Operating Expenses with 21% Decline in Third Quarter 2021 First Production Run of MP Combat Energy Successfully Sold 100%; $30 Million of Annual Sales Expected in 2023 Company Expects Sequential Revenue Growth in Fourth Quarter 2021 fromNew Product Formulation and MP Energy Drink Line LAS VEGAS, Nov. 15, 2021 (GLOBE NEWSWIRE) — MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported financial results for the third quarter and nine months ended September 30, 2021. Mr. Ryan Drexler, the Chairman of the Board of Directors and Chief Executive Officer, stated, “Sales and margins in the third quarter were impacted by supply chain shortages which were mitigated by our continued focus on operating expense...

Set to Expand Partnerships with Costco and Walmart in 2022Net Sales Increased 104.6% Year Over Year to $9.1 MillionReaffirms 2021 Financial Outlook of Net Sales of $31 Million to $34 Million PLANO, Texas, Nov. 15, 2021 (GLOBE NEWSWIRE) — Stryve Foods, Inc. (“Stryve” or “the Company”), (NASDAQ: SNAX), an emerging healthy snack and eating platform disrupting traditional consumer packaged goods (CPG) categories, and a leader in the air-dried meat snack industry in the United States, today announced results for the third quarter ended September 30, 2021 and provided a business update. Joe Oblas, CEO and Co-Founder, stated, “We are very pleased to have more than doubled our top-line and gross profit during the third quarter compared to the year-ago period, reflecting robust gains across our wholesale and e-commerce channels as we successfully...

Successfully Closed Business Combination with Spartacus Acquisition Corporation Signed Major Partnerships with Industry Leaders Including Qualcomm Technologies, Atlas: Earth and MetCom; Launched Unreal Engine Plug-In Year-to-Date Revenue Up 60% Year-over-Year on Growing Customer and Platform Adoption MCLEAN, Va., Nov. 15, 2021 (GLOBE NEWSWIRE) — NextNav Inc. (NASDAQ: NN) (“NextNav” or the “Company”), a leader in next generation GPS and 3D geolocation, today reported financial results for NextNav’s third quarter ended September 30, 2021 achieved prior to the completion of the company’s business combination with Spartacus Acquisition Corp. on October 28, 2021. Ganesh Pattabiraman, NextNav Co-founder and CEO, stated, “We are thrilled to have successfully completed our business combination with Spartacus Acquisition Corp., and to now...

-Top-line data readout from TERN-201 (VAP-1) clinical trial in NASH expected in 1Q 2022 -Positive top-line data from TERN-501 (THR-β) demonstrated clinical proof of concept, enabling the planned initiation of NASH trial in 1H 2022 -Multiple abstracts detailing positive clinical data for TERN-101 and TERN-501 presented at AASLD 2021 -Cash and equivalents of $177 million provides runway into 2024 FOSTER CITY, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address serious diseases such as non-alcoholic steatohepatitis (NASH), today reported financial results for the third quarter ended September 30, 2021 and corporate highlights. “Recent...

PITTSBURGH, Pa., Nov. 15, 2021 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the third quarter of 2021. Third Quarter Financial Highlights:Revenues of $39.7 million, increased 40.7% year-over-yearNet Income of $8.9 million, increased 526.9% year-over-yearNon-GAAP Adjusted EBITDA of $12.8 million, increased 27.2% year-over-yearRNG production of 1.5 million MMBtu, decreased (0.7%) year-over-yearMontauk’s third quarter revenue reflects an increase in the number of RINs sold based on inter-period timing on RIN transfers. To a lesser extent, increased natural gas prices and higher revenues recognized under counterparty...

Q3 2021 Net Income of $148,000 versus Q3 2020 Net Loss of ($323,000) PORTLAND, Maine, Nov. 15, 2021 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the third quarter and the nine-month period ended September 30, 2021. Product Sales Results:During the three-month period ended September 30, 2021, total product sales increased by 38%, or $1.4 million, to $5.2 million versus the three-month period ended September 30, 2020. During the nine-month period ended September 30, 2021, total product sales increased by 19%, or $2.2 million, to $13.8 million versus the nine-month...

Third Quarter 2021 HighlightsRevenue Increased 12.4% to $411.3 Million Gross Margin Increased 22.4% to $139.7 Million Net Income of $2.1 Million, or $0.01 per Diluted Share Adjusted Net Income per Diluted Share of $0.11 Adjusted EBITDA Increased 14.6% to $45.8 Million Agrees to Acquire Comfort Care on September 27 (HHH, approximately $97 million revenue) Agrees to Acquire Accredited on November 12 (PDS, approximately $115 million revenue)ATLANTA, Nov. 15, 2021 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods ended October 2, 2021. Tony Strange, Chief Executive Officer, commented, “We are pleased with our solid...